-
公开(公告)号:US20120115867A1
公开(公告)日:2012-05-10
申请号:US13100670
申请日:2011-05-04
申请人: Saverio Minucci , Pier Giuseppe Pelicci , Antonello Mai , Marco Ballarini , Gaetano Gargiulo , Silvio Massa , Florian Thaler , Gilles Pain , Andrea Colombo , Stefania Gagliardi , Mario Varasi , Ciro Mercurio
发明人: Saverio Minucci , Pier Giuseppe Pelicci , Antonello Mai , Marco Ballarini , Gaetano Gargiulo , Silvio Massa , Florian Thaler , Gilles Pain , Andrea Colombo , Stefania Gagliardi , Mario Varasi , Ciro Mercurio
IPC分类号: A61K31/495 , C07D401/10 , A61P35/00 , C07D413/06 , A61K31/5377 , C07D295/155 , A61K31/496
CPC分类号: C07D295/155 , C07D213/54 , C07D401/10
摘要: This invention is related to new histone deacetylase inhibitors according to the general formula (I) wherein: Q is a bond, CH2, NR5 or oxygen, X is CH or nitrogen, Y is a bond, CH2, oxygen or NR6, Z is CH or nitrogen, R1, R2 are, independently, hydrogen or C1-C6 alkyl, R3, R4 are, independently, hydrogen, halogen, C1-C6 alkyl, C1-C6 alkoxy, C1-C6 haloalkyl or C1-C6 haloalkoxy, and R5 and R6 are as further defined in the specification, and pharmaceutical acceptable salts thereof.
摘要翻译: 本发明涉及根据通式(I)的新的组蛋白脱乙酰酶抑制剂,其中:Q是键,CH2,NR5或氧,X是CH或氮,Y是键,CH2,氧或NR6,Z是CH 或氮,R 1,R 2独立地为氢或C 1 -C 6烷基,R 3,R 4独立地为氢,卤素,C 1 -C 6烷基,C 1 -C 6烷氧基,C 1 -C 6卤代烷基或C 1 -C 6卤代烷氧基, 和R6在说明书中进一步定义,及其药学上可接受的盐。
-
公开(公告)号:US20110105474A1
公开(公告)日:2011-05-05
申请号:US12997191
申请日:2009-06-08
申请人: Florian Thaler , Mario Varasi , Stefania Gagliardi , Andrea Colombo , Saverio Minucci , Ciro Mercurio
发明人: Florian Thaler , Mario Varasi , Stefania Gagliardi , Andrea Colombo , Saverio Minucci , Ciro Mercurio
IPC分类号: A61K31/495 , A61K31/55 , A61K31/506 , A61K31/496 , A61K31/444 , A61K31/4545 , A61K31/4439 , A61K31/407 , C07D401/14 , C07D401/06 , C07D295/192 , C07D471/10 , C07D471/04 , C07D401/04 , C07D487/08 , C07D241/04 , A61P35/00
CPC分类号: C07D295/10 , C07D211/58 , C07D295/18 , C07D401/06 , C07D401/14 , C07D471/08 , C07D471/10
摘要: This invention is related to new histone deacetylase inhibitors according to the general formula (I) wherein: the dotted line is an optional additional bond; R1 is hydrogen, halogen, C1-C6 alkyl, C1-C6 alkoxy, C1-C6 haloalkyl or C1 C6 haloalkoxy; R2, R3 are, independently, hydrogen; C1-C6 alkyl; aryl; or taken together with the carbon atoms to which they are bound form a bridged bicyclic ring or a fused heterocycle; X is CH or nitrogen; Y is a bond, oxygen, (CH2)mCR4R5(CH2)n, or (CH2)oNR6(CH2)p; m, n, o, p, R4, R5 and R6 are as further defined in the specification; and pharmaceutical acceptable salts thereof.
摘要翻译: 本发明涉及根据通式(I)的新的组蛋白脱乙酰酶抑制剂,其中:虚线是任选的附加键; R 1是氢,卤素,C 1 -C 6烷基,C 1 -C 6烷氧基,C 1 -C 6卤代烷基或C 1 -C 6卤代烷氧基; R2,R3独立地是氢; C1-C6烷基; 芳基; 或与其结合的碳原子一起形成桥连双环或稠合杂环; X是CH或氮; Y是键,氧,(CH 2)m CR 4 R 5(CH 2)n或(CH 2)o NR 6(CH 2)p; m,n,o,p,R4,R5和R6如说明书中进一步定义; 及其药学上可接受的盐。
-
公开(公告)号:US20100305123A1
公开(公告)日:2010-12-02
申请号:US12675305
申请日:2008-08-26
申请人: Florian Thaler , Mario Varasi , Ciro Mercurio , Saverio Minucci , Andrea Colombo , Stefania Gagliardi
发明人: Florian Thaler , Mario Varasi , Ciro Mercurio , Saverio Minucci , Andrea Colombo , Stefania Gagliardi
IPC分类号: A61K31/5377 , C07D295/155 , C07D401/10 , C07D413/10 , A61K31/495 , A61K31/496 , A61P35/00 , A61P35/02 , A61P9/10 , A61P37/06 , A61P31/00 , A61P19/02 , A61P17/06
CPC分类号: C07D241/04 , C07D401/10 , C07D413/10
摘要: This invention is related to new histone deacetylase inhibitors according to the general formula (I) wherein: Q is a bond, CH2, NR5 or oxygen, X is CH or nitrogen, Y is a bond, CH2, oxygen or NR6, Z is CH or nitrogen, R1, R2 are, independently, hydrogen or C1-C6 alkyl, R3, R4 are, independently, hydrogen, halogen, C1-C6 alkyl, C1-C6 alkoxy, C1-C6 haloalkyl or C1-C6 haloalkoxy, and R5 and R6 are as further defined in the specification, and pharmaceutical acceptable salts thereof.
摘要翻译: 本发明涉及根据通式(I)的新的组蛋白脱乙酰酶抑制剂,其中:Q是键,CH2,NR5或氧,X是CH或氮,Y是键,CH2,氧或NR6,Z是CH 或氮,R 1,R 2独立地为氢或C 1 -C 6烷基,R 3,R 4独立地为氢,卤素,C 1 -C 6烷基,C 1 -C 6烷氧基,C 1 -C 6卤代烷基或C 1 -C 6卤代烷氧基, 和R6在说明书中进一步定义,及其药学上可接受的盐。
-
公开(公告)号:US20120258949A1
公开(公告)日:2012-10-11
申请号:US13446861
申请日:2012-04-13
申请人: Mario Varasi , Florian Thaler , Raffaella Amici , Agnese Abate , Maria Carmela Fulco , Saverio Minucci , Ciro Mercurio
发明人: Mario Varasi , Florian Thaler , Raffaella Amici , Agnese Abate , Maria Carmela Fulco , Saverio Minucci , Ciro Mercurio
IPC分类号: A61K31/407 , A61K31/438 , A61K31/55 , A61K31/397 , C07D498/10 , A61K31/537 , A61P35/00 , A61P25/00 , A61P29/00 , A61P31/00 , A61P11/00 , A61P37/00 , A61P9/00 , A61P21/00 , A61P17/06 , C07D491/107
CPC分类号: A61K31/397 , A61K31/407 , A61K31/438 , A61K31/537 , A61K31/55 , C07D491/107 , C07D498/10
摘要: This invention is related to new histone deacetylase inhibitors according to the general formula (I), wherein: m and n are independently zero or an integer from 1 to 4; p is zero or an integer from 1 to 3, with the proviso that when p is zero, n and m cannot be both 1; R is hydrogen; C1-C6 alkyl, optionally substituted by C3-C8 cycloalkyl, C6-C10 aryl or hetero(C2-C9)aryl; (CO)R2; (SO2)R3; C3-C8 cycloalkyl; C6-C10 aryl; or hetero(C2-C9)aryl; R1 is halogen, C1-C6 alkyl, C1-C6 haloalkyl, C1-C6 alkoxy, C1-C6 haloalkoxy; Y is CH2 or NR4; Z is C═R5; and R2, R3, R4, and R5 are as further defined in the specification; and pharmaceutical acceptable salts thereof.
摘要翻译: 本发明涉及根据通式(I)的新的组蛋白脱乙酰酶抑制剂,其中:m和n独立地为0或1至4的整数; p为0或1至3的整数,条件是当p为零时,n和m不能同时为1; R是氢; 任选被C 3 -C 8环烷基,C 6 -C 10芳基或杂(C 2 -C 9)芳基取代的C 1 -C 6烷基; (CO)R2; (SO2)R3; C3-C8环烷基; C6-C10芳基; 或杂(C 2 -C 9)芳基; R1是卤素,C1-C6烷基,C1-C6卤代烷基,C1-C6烷氧基,C1-C6卤代烷氧基; Y是CH 2或NR 4; Z为C = R5; R2,R3,R4和R5如说明书中进一步定义; 及其药学上可接受的盐。
-
公开(公告)号:US08592444B2
公开(公告)日:2013-11-26
申请号:US12988197
申请日:2009-04-14
申请人: Mario Varasi , Florian Thaler , Agnese Abate , Giacomo Carenzi , Ciro Mercurio , Saverio Minucci
发明人: Mario Varasi , Florian Thaler , Agnese Abate , Giacomo Carenzi , Ciro Mercurio , Saverio Minucci
IPC分类号: C07D401/04 , A61K31/438
CPC分类号: C07D498/10 , A61K31/438 , C07D471/10 , C07D491/107 , Y02A50/409 , Y02A50/411
摘要: This invention is related to new histone deacetylase inhibitors according to the general formula (I) wherein: the dotted line is an optional additional bond; n is zero or an integer from 1 to 4; R1 is hydrogen; C1-C6 alkyl, optionally substituted by cycloalkyl, aryl or by heteroaryl; (CO)R3; (SO2)R4; cycloalkyl; aryl; or heteroaryl; R2 is C1-C6 alkyl, optionally substituted by aryl or by heteroaryl; aryl; heteroaryl; or (CO)R5; X is CH2, oxygen or NR6; Y is a bond, CHR7 or NR8; Z is oxygen, CR9R10 or C═R11; and R3, R4, R5, R6, R7, R8, R9, R10 and R11 are as further defined in the specification; and pharmaceutical acceptable salts thereof.
摘要翻译: 本发明涉及根据通式(I)的新的组蛋白脱乙酰酶抑制剂,其中:虚线是任选的附加键; n为0或1至4的整数; R1是氢; 任选被环烷基,芳基或杂芳基取代的C 1 -C 6烷基; (CO)R3; (SO2)R4; 环烷基 芳基; 或杂芳基; R2是任选被芳基或杂芳基取代的C 1 -C 6烷基; 芳基; 杂芳基; 或(CO)R5; X是CH 2,氧或NR 6; Y是一个键,CHR7或NR8; Z是氧,CR9R10或C = R11; R3,R4,R5,R6,R7,R8,R9,R10和R11在说明书中进一步定义; 及其药学上可接受的盐。
-
公开(公告)号:US20110039840A1
公开(公告)日:2011-02-17
申请号:US12988197
申请日:2009-04-14
申请人: Mario Varasi , Florian Thaler , Agnese Abate , Giacomo Carenzi , Ciro Mercurio , Saverio Minucci
发明人: Mario Varasi , Florian Thaler , Agnese Abate , Giacomo Carenzi , Ciro Mercurio , Saverio Minucci
IPC分类号: A61K31/537 , C07D491/10 , A61K31/438 , A61P35/00 , A61P31/18 , A61P25/08 , A61P9/10 , A61P37/00 , A61P17/06 , A61P35/04 , A61P25/16 , A61P25/28 , A61P25/18 , A61P33/06 , A61P33/02 , A61P31/10 , A61P31/12 , C07D498/10 , C07D471/10 , A61K31/527 , A61K31/506
CPC分类号: C07D498/10 , A61K31/438 , C07D471/10 , C07D491/107 , Y02A50/409 , Y02A50/411
摘要: This invention is related to new histone deacetylase inhibitors according to the general formula (I) wherein: the dotted line is an optional additional bond; n is zero or an integer from 1 to 4; R1 is hydrogen; C1-C6 alkyl, optionally substituted by cycloalkyl, aryl or by heteroaryl; (CO)R3; (SO2)R4; cycloalkyl; aryl; or heteroaryl; R2 is C1-C6 alkyl, optionally substituted by aryl or by heteroaryl; aryl; heteroaryl; or (CO)R5; X is CH2, oxygen or NR6; Y is a bond, CHR7 or NR8; Z is oxygen, CR9R10 or C═R11; and R3, R4, R5, R6, R7, R8, R9, R10 and R11 are as further defined in the specification; and pharmaceutical acceptable salts thereof.
摘要翻译: 本发明涉及根据通式(I)的新的组蛋白脱乙酰酶抑制剂,其中:虚线是任选的附加键; n为0或1至4的整数; R1是氢; 任选被环烷基,芳基或杂芳基取代的C 1 -C 6烷基; (CO)R3; (SO2)R4; 环烷基 芳基; 或杂芳基; R2是任选被芳基或杂芳基取代的C 1 -C 6烷基; 芳基; 杂芳基; 或(CO)R5; X是CH 2,氧或NR 6; Y是一个键,CHR7或NR8; Z是氧,CR9R10或C = R11; R3,R4,R5,R6,R7,R8,R9,R10和R11在说明书中进一步定义; 及其药学上可接受的盐。
-
公开(公告)号:US08980877B2
公开(公告)日:2015-03-17
申请号:US13446861
申请日:2012-04-13
申请人: Mario Varasi , Florian Thaler , Raffaella Amici , Agnese Abate , Maria Carmela Fulco , Saverio Minucci , Ciro Mercurio
发明人: Mario Varasi , Florian Thaler , Raffaella Amici , Agnese Abate , Maria Carmela Fulco , Saverio Minucci , Ciro Mercurio
IPC分类号: A61K31/407 , A61K31/438 , A61K31/55 , C07D491/107 , A61K31/397 , A61K31/537 , C07D498/10
CPC分类号: A61K31/397 , A61K31/407 , A61K31/438 , A61K31/537 , A61K31/55 , C07D491/107 , C07D498/10
摘要: This invention is related to new histone deacetylase inhibitors according to the general formula (I), wherein: m and n are independently zero or an integer from 1 to 4; p is zero or an integer from 1 to 3, with the proviso that when p is zero, n and m cannot be both 1; R is hydrogen; C1-C6 alkyl, optionally substituted by C3-C8 cycloalkyl, C6-C10 aryl or hetero(C2-C9)aryl; (CO)R2; (SO2)R3; C3-C8 cycloalkyl; C6-C10 aryl; or hetero(C2-C9)aryl; R1 is halogen, C1-C6 alkyl, C1-C6 haloalkyl, C1-C6 alkoxy, C1-C6 haloalkoxy; Y is CH2 or NR4; Z is C═R5; and R2, R3, R4, and R5 are as further defined in the specification; and pharmaceutical acceptable salts thereof.
摘要翻译: 本发明涉及根据通式(I)的新的组蛋白脱乙酰酶抑制剂,其中:m和n独立地为0或1至4的整数; p为0或1至3的整数,条件是当p为零时,n和m不能同时为1; R是氢; 任选被C 3 -C 8环烷基,C 6 -C 10芳基或杂(C 2 -C 9)芳基取代的C 1 -C 6烷基; (CO)R2; (SO2)R3; C3-C8环烷基; C6-C10芳基; 或杂(C 2 -C 9)芳基; R1是卤素,C1-C6烷基,C1-C6卤代烷基,C1-C6烷氧基,C1-C6卤代烷氧基; Y是CH 2或NR 4; Z为C = R5; R2,R3,R4和R5如说明书中进一步定义; 及其药学上可接受的盐。
-
公开(公告)号:US20140080823A1
公开(公告)日:2014-03-20
申请号:US14088061
申请日:2013-11-22
申请人: Mario Varasi , Florian Thaler , Agnese Abate , Giacomo Carenzi , Ciro Mercurio , Saverio Minucci
发明人: Mario Varasi , Florian Thaler , Agnese Abate , Giacomo Carenzi , Ciro Mercurio , Saverio Minucci
IPC分类号: C07D498/10 , C07D471/10 , C07D491/107
CPC分类号: C07D498/10 , A61K31/438 , C07D471/10 , C07D491/107 , Y02A50/409 , Y02A50/411
摘要: This invention is related to new histone deacetylase inhibitors according to the general formula (I) wherein: the dotted line is an optional additional bond; n is zero or an integer from 1 to 4; R1 is hydrogen; C1-C6 alkyl, optionally substituted by cycloalkyl, aryl or by heteroaryl; (CO)R3; (SO2)R4; cycloalkyl; aryl; or heteroaryl; R2 is C1-C6 alkyl, optionally substituted by aryl or by heteroaryl; aryl; heteroaryl; or (CO)R5; X is CH2, oxygen or NR6; Y is a bond, CHR7 or NR8; Z is oxygen, CR9R10 or C═R11; and R3, R4, R5, R6, R7, R8, R9, R10 and R11 are as further defined in the specification; and pharmaceutical acceptable salts thereof.
摘要翻译: 本发明涉及根据通式(I)的新的组蛋白脱乙酰酶抑制剂,其中:虚线是任选的附加键; n为0或1至4的整数; R1是氢; 任选被环烷基,芳基或杂芳基取代的C 1 -C 6烷基; (CO)R3; (SO2)R4; 环烷基 芳基; 或杂芳基; R2是任选被芳基或杂芳基取代的C 1 -C 6烷基; 芳基; 杂芳基; 或(CO)R5; X是CH 2,氧或NR 6; Y是一个键,CHR7或NR8; Z是氧,CR9R10或C = R11; R3,R4,R5,R6,R7,R8,R9,R10和R11在说明书中进一步定义; 及其药学上可接受的盐。
-
公开(公告)号:US08242175B2
公开(公告)日:2012-08-14
申请号:US12962209
申请日:2010-12-07
申请人: Antonello Mai , Saverio Minucci , Florian Thaler , Gilles Pain , Andrea Colombo , Stefania Gagliardi , Pier Giuseppe Pelicci , Marco Ballarini , Gaetano Gargiulo , Silvio Massa
发明人: Antonello Mai , Saverio Minucci , Florian Thaler , Gilles Pain , Andrea Colombo , Stefania Gagliardi , Pier Giuseppe Pelicci , Marco Ballarini , Gaetano Gargiulo , Silvio Massa
IPC分类号: A61K31/19 , A61K31/5377 , A61K31/495 , A61K31/451 , A61K31/445 , A61K31/5375 , A61K31/496 , A61P35/00 , C07D295/155 , C07D211/58 , C07D401/10 , C07D413/10 , C07C259/06
CPC分类号: C07D401/10 , C07D211/58 , C07D213/50 , C07D213/54 , C07D241/04 , C07D265/30 , C07D295/112 , C07D333/56
摘要: New histone deacetylase inhibitors according to the general formula (I) wherein: Q is a bond, CH2, CH—NR3R4, NR5 or oxygen, X is CH or nitrogen, Y is a bond, CH2, oxygen or NR6, Z is CH or nitrogen, R1, R2 are, independently, hydrogen, halogen, C1-C6 alkyl or C1-C6 haloalkyl, R11, R12 are, independently, hydrogen or C1-C6 alkyl, and R3, R4, R5 and R6 are as further defined in the specification.
摘要翻译: 根据通式(I)的新的组蛋白脱乙酰酶抑制剂其中:Q是键,CH2,CH-NR3R4,NR5或氧,X是CH或氮,Y是键,CH2,氧或NR6,Z是CH或 氮,R 1,R 2独立地是氢,卤素,C 1 -C 6烷基或C 1 -C 6卤代烷基,R 11,R 12独立地是氢或C 1 -C 6烷基,R 3,R 4,R 5和R 6如 规格。
-
公开(公告)号:US20110077247A1
公开(公告)日:2011-03-31
申请号:US12962209
申请日:2010-12-07
申请人: Antonello Mai , Saverio Minucci , Florian Thaler , Gilles Pain , Andrea Colombo , Stefania Gagliardi , Pier Giuseppe Pelicci , Marco Ballarini , Gaetano Gargiulo , Silvio Massa
发明人: Antonello Mai , Saverio Minucci , Florian Thaler , Gilles Pain , Andrea Colombo , Stefania Gagliardi , Pier Giuseppe Pelicci , Marco Ballarini , Gaetano Gargiulo , Silvio Massa
IPC分类号: A61K31/5377 , C07D295/155 , A61K31/495 , C07D211/58 , A61K31/451 , A61K31/445 , A61K31/5375 , C07D401/10 , A61K31/496 , C07D413/10 , A61P35/00
CPC分类号: C07D401/10 , C07D211/58 , C07D213/50 , C07D213/54 , C07D241/04 , C07D265/30 , C07D295/112 , C07D333/56
摘要: New histone deacetylase inhibitors according to the general formula (I) wherein: Q is a bond, CH2, CH—NR3R4, NR5 or oxygen, X is CH or nitrogen, Y is a bond, CH2, oxygen or NR6, Z is CH or nitrogen, R1, R2 are, independently, hydrogen, halogen, C1-C6 alkyl or C1-C6 haloalkyl, R11, R12 are, independently, hydrogen or C1-C6 alkyl, and R3, R4, R5 and R6 are as further defined in the specification.
摘要翻译: 根据通式(I)的新的组蛋白脱乙酰酶抑制剂其中:Q是键,CH2,CH-NR3R4,NR5或氧,X是CH或氮,Y是键,CH2,氧或NR6,Z是CH或 氮,R 1,R 2独立地是氢,卤素,C 1 -C 6烷基或C 1 -C 6卤代烷基,R 11,R 12独立地是氢或C 1 -C 6烷基,R 3,R 4,R 5和R 6如 规格。
-
-
-
-
-
-
-
-
-